AVAL
Grupo Aval Acciones y Valores S.A.
There isn't enough reported data to score AVAL yet.
MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
AVAL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
AVAL's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like AVAL.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
AVAL PE Valuation
AVAL has no meaningful PE right now: it lost money over the past year.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
AVAL Forward outlook
There aren't enough analyst estimates for AVAL to show an outlook.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
AVAL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.44 | +10% |
| Q1 2026 | $0.43 | +34% |
| Q4 2025 | $0.44 | +69% |
| Q3 2025 | $0.42 | +100% |
| Q2 2025 | $0.40 | +233% |
| Q1 2025 | $0.32 | +191% |
| Q4 2024 | $0.26 | +44% |
| Q3 2024 | $0.21 | +163% |
AVAL has the edge over MS on earnings, with stronger typical year-over-year growth.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
AVAL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.5B | +25% |
| Q1 2026 | $2.9B | +7.6% |
| Q4 2025 | $3.5B | +31% |
| Q3 2025 | $2.8B | +0.6% |
| Q2 2025 | $2.8B | +0.7% |
| Q1 2025 | $2.7B | -6.1% |
| Q4 2024 | $2.7B | -9.1% |
| Q3 2024 | $2.8B | -0.8% |
AVAL's revenue has grown year over year for five quarters in a row: $3.5B last quarter, up 25% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 11% | -2.3 points |
| Q1 2026 | 14% | +0.8 points |
| Q4 2025 | 9.4% | +2.5 points |
| Q3 2025 | 13% | +1.8 points |
| Q2 2025 | 14% | +5.4 points |
| Q1 2025 | 13% | +5.8 points |
| Q4 2024 | 6.9% | +0.5 points |
| Q3 2024 | 11% | +6.4 points |
AVAL's operating margin was 11% last quarter, down 2.3 points from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over AVAL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over AVAL on profitability, with a higher operating margin.
AVAL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $612.6M | +80% |
| Q1 2026 | -$32.5M | -136% |
| Q4 2025 | -$342.6M | +$627.2M |
| Q3 2025 | $394.5M | +81% |
| Q2 2025 | $339.9M | +$2.7B |
| Q1 2025 | $89.7M | +$1.4B |
| Q4 2024 | -$969.8M | -$494.2M |
| Q3 2024 | $217.7M | +223% |
AVAL has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
AVAL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | 0% | +13 shares |
| 5 years | +6.6% | +73.1M shares |
| Available history | +6.6% | +73.1M shares |
AVAL has 1.2B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $16.7M |
| Q3 2024 | — |
AVAL hasn't bought back shares in the past year.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over AVAL on shareholder dilution, with a more favorable share count trend.
AVAL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 8.6x | High |
| Q1 2026 | 7.3x | High |
| Q4 2025 | 9.2x | High |
| Q3 2025 | 11.5x | High |
| Q2 2025 | 10.3x | High |
| Q1 2025 | 11.4x | High |
| Q4 2024 | 14.5x | High |
| Q3 2024 | 13.5x | High |
AVAL's net debt is about 8.6 years of its operating earnings (EBITDA), down from 10 years a year ago. Net leverage isn't a meaningful measure for financial services companies like AVAL.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS has the edge over AVAL on leverage, with a lower net debt burden relative to earnings.
AVAL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.9 | Neutral |
| Stochastic | 5.3 | Oversold |
AVAL's weekly RSI is 35 (neutral) and its Stochastic is 5 (oversold).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
AVAL PE vs Financial Services Sector
AVAL has no meaningful PE right now: it lost money over the past year.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
AVAL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.63 | 15% below |
| 20 week MA | $4.95 | 20% below |
| 50 week MA | $4.65 | 15% below |
| 100 week MA | $3.83 | 3.1% above |
| 200 week MA | $3.07 | 29% above |
AVAL has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 29% above its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over AVAL on trend strength, trading above more of its moving averages.
AVAL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.72 | $6.86 | -21% |
| 2021 | $6.86 | $5.24 | -24% |
| 2022 | $5.24 | $2.33 | -56% |
| 2023 | $2.33 | $2.43 | +4.3% |
| 2024 | $2.43 | $2.07 | -15% |
| 2025 | $2.07 | $4.23 | +104% |
| 2026 YTD | $4.23 | $3.95 | -6.6% |
AVAL's yearly returns have swung widely, from +104% in 2025 to −56% in 2022. It's down 6.6% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over AVAL on returns for 2026, with the stronger performance.